OA
EW icon

Oak Associates’s Edwards Lifesciences EW Stock Holding History

Oak Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-69,000
Closed -$1.64M – 160
2015
Q2 		$1.64M Buy
+69,000
New +$1.56M 0.2% 97

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Oak Associates's EW Position: Q3 2015 in Review

Oak Associates sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 69,000 shares — an estimated $1.64M sold.

Oak Associates first reported a position in EW in Q2 2015 and held it in 1 quarter. The position peaked at $1.64M in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • Oak Associates reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
  • Oak Associates sold 69,000 Edwards Lifesciences shares in Q3 2015, an estimated $1.64M.
  • Oak Associates first reported a position in Edwards Lifesciences in Q2 2015 and held it in 1 quarter.
  • Oak Associates's Edwards Lifesciences position peaked at $1.64M in Q2 2015.
  • 569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Oak Associates's 13F filing for Q3 2015, filed 16 Nov 2015.